Recall of 4 batches of injections caused by solution crystallization
Jingfeng Medicine Tirofiban Hydrochloride and Sodium Chloride Injection Passed the Consistency Evaluation
and only costs about 1,000 yuan for the entire injection.
The KHB-1802 project of Kanghong Pharmaceutical Conbercept ophthalmic injection is suspended in France
Millions of viruses have been injected into the brain, and the survival period of children with fatal tumors has more than doubled!
Heavy | Binhui Bio-Clinical Cooperation Agency Announces Phase I/II Clinical Data of Oncolytic Herpes Simplex Virus Type II OH2 Injection
Two injections of Renfu Medicine passed the consistency evaluation of generic drugs
Hengrui Medicine: Cisatracurium Benzene Sulfonate Injection Passed the Consistency Evaluation of Generic Drugs
BeiGene TIGIT monoclonal antibody BGB-A1217 injection was approved for clinical use
Junshi Biologics JS007 injection clinical trial application accepted
Kelun Class 1 new drug hits 2 billion injections, the first four major products that have been reviewed and will be approved
Kanghong Pharmaceutical Stops Global Multicenter Clinical Trial of Conbercept Ophthalmic Injection
Haohaishengke: Injection molding and astigmatism intraocular lens products obtained EU CE certification
Huadong Medicine's polycaprolactone microsphere facial filler for injection obtained medical device registration certificate
France suspends Conbercept ophthalmic injection KHB-1802 project, Kanghong Pharmaceutical's stock price fluctuations
On the evening of March 28, Kanghong Pharmaceutical issued an announcement stating that the French National Agency
The first imitation of Haisco's anti-ED drug is approved, and the blockbuster injection will start phase III clinical trials
Recently, high scores have been reported frequently by Haisco.
On March 29, two consecutive product announcements
Yangtze River Health: Ceftazidime for injection in its subsidiary passed the consistency evaluation
Preliminary Pharmaceuticals obtains marketing approval for ganciclovir for injection from the Italian Food and Drug Administration
Shisiyao has been approved for imitation of Bromhexine Hydrochloride injection for production of Category 3